Princeton Bao Aff
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| All | 1 | Any | Any |
|
| ||
| Yale University Invitational 2021 | 2 | Montville RP | Alex Rivera |
|
|
| |
| Yale University Invitational 2021 | 3 | Scarsdale OL | David Herrera |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Yale University Invitational 2021 | 2 | Opponent: Montville RP | Judge: Alex Rivera 1AC Evergreening |
| Yale University Invitational 2021 | 3 | Opponent: Scarsdale OL | Judge: David Herrera 1AC Evergreening |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
0 - Contact InfoTournament: All | Round: 1 | Opponent: Any | Judge: Any Please let me know if you want me to disclose any way! This is also terminal defense to any disclosure theory shells. Also, if there are any trigger warnings you'd like me to provide, please let me know! My top priority is to have a safe debate! If I read the same position twice, I won't redisclose absent card changes so the wiki doesn't get cluttered. | 7/6/21 |
GENERAL - Underview v1Tournament: Yale University Invitational 2021 | Round: 3 | Opponent: Scarsdale OL | Judge: David Herrera Theory Issues1~ 1AR theory – a) AFF gets it because otherwise the neg can engage in infinite abuse, making debate impossible, b) drop the debater – the 1AR is too short for theory and substance so ballot implications are key to check abuse, c) no RVIs – they can stick me with 6min of answers to a short arg and make the 2AR impossible, d) competing interps – 1AR interps aren’t bidirectional and the neg should have to defend their norm since they have more time.2~ Permissibility and presumption affirm:a) Probability: in a world where anything is permissible people don’t just do nothing they do whatever which means there’s a higher probability of the aff than the squo.b) Negating an obligation requires proving a prohibition – means permissibility affirms because negating is prohibiting the aff action.c) Otherwise people would have to justify neutral actions like drinking waterd) We believe things true before proving them false: i.e. you’d believe my name is Chris unless told otherwise | 9/18/21 |
GENERAL - Util v1Tournament: Yale University Invitational 2021 | Round: 2 | Opponent: Montville RP | Judge: Alex Rivera FramingThe standard is maximizing expected well-being, or hedonistic act util. Prefer it:1~ Actor specificity: util is the best for governments, which is the actor in the rez – multiple warrants:~a~ Governments must aggregate since every policy benefits some and harms others, which also means side constraints freeze action.~b~ Actor-specificity comes first since different agents have different ethical standings. Takes out util calc indicts since they’re empirically denied and link turns them because the alt would be no action.2~ Extinction outweighsPummer 15 ~Theron, Junior Research Fellow in Philosophy at St. Anne's College, University of Oxford. "Moral Agreement on Saving the World" Practical Ethics, University of Oxford. May 18, 2015~ AT AND If our selfish recklessness ends human history, we would be acting very wrongly." (From chapter 36 of On What Matters) Method1~ Policy education is key to portable advocacyNixon 2K Makani Themba-Nixon, Executive Director of The Praxis Project. "Changing the Rules: What Public Policy Means for Organizing." Colorlines 3.2, 2000. AND to our vision of how things should be. And then we must be committed to making it so. | 9/18/21 |
SO - LARP - EvergreeningTournament: Yale University Invitational 2021 | Round: 2 | Opponent: Montville RP | Judge: Alex Rivera 1AC: InnovationAdvantage 1 is InnovationWe are in an innovation crisis – new drugs are not being developed in favor of re-purposing old drugs to infinitely extend patent expiration.Feldman 1 Robin Feldman 2-11-2019 "‘One-and-done’ for new drugs could cut patent thickets and boost generic competition" https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/ (Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson ’54 Distinguished Professor of Law Chair, and Director of the Center for Innovation)SidK + Elmer AND look for new things, not to recycle existing drugs for minimal benefit. The only major study confirms our Internal Link – Evergreening decimates competition by resulting in functional monopoliesArnold Ventures 20 9-24-2020 "'Evergreening' Stunts Competition, Costs Consumers and Taxpayers" https://www.arnoldventures.org/stories/evergreening-stunts-competition-costs-consumers-and-taxpayers/ (Arnold Ventures is focused on evidence-based giving in a wide range of categories including: criminal justice, education, health care, and public finance)Elmer AND billions of dollars while increasing the incentives for pharmaceutical companies to achieve breakthroughs." Specifically, prevents effective cancer treatment via skyrocketing prices.Kantarjian 15 ~Hagop Kantarjian, M.D., is the Chair of the Leukemia department at MD Anderson Cancer Center. March 16, 2015. "Why Are Cancer Drugs So Expensive in the United States, and What Are the Solutions?". https://www.mayoc linicproceedings.org/article/S0025-6196(15)00101-9/fulltext~#20~ Dhruv AND lobbying spending of the defense, aerospace, and gas and oil companies. Contagious Cancer is a major and legitimate threat AND causes extinction.Johnson 16 George Johnson 2-23-2016 "Scientists Ponder the Prospect of Contagious Cancer" https://www.nytimes.com/2016/02/23/science/scientists-ponder-the-prospect-of-contagious-cancer.html?mcubz=0 (columnist and science journalist for the New York Times, M.A. in Journalism and Public Affairs, American University)Elmer AND to leap to another body. Otherwise, contagious cancer would be everywhere. Only innovation now solves AMR super-bugs — timeframe’s key.Sobti 19 ~Dr. Navjot Kaur Sobti is an internal medicine resident physician at Dartmouth-Hitchcock-Medical Center/Dartmouth School of Medicine and a member of the ABC News Medical Unit. May 1, 2019. "Amid superbug crisis, scientists urge innovation". https://abcnews.go.com/Health/amidst-superbug-crisis-scientists-urge-innovation/story?id=62763415~~ Dhruv AND generations to come and secure the future from drug-resistant diseases." Extinction - generic defense doesn’t apply.Srivatsa 17 Kadiyali Srivatsa 1-12-2017 "Superbug Pandemics and How to Prevent Them" https://www.the-american-interest.com/2017/01/12/superbug-pandemics-and-how-to-prevent-them/ (doctor, inventor, and publisher. He worked in acute and intensive pediatric care in British hospitals)Elmer AND A flu-like disease could kill more than 33 million people in 250 days.3 Pharma spills-over – has cascading global impacts that are necessary for human survival.NAS 8 National Academy of Sciences 12-3-2008 "The Role of the Life Sciences in Transforming America's Future Summary of a Workshop" Re-cut by Elmer AND biological processes at work in the oceans can humans live sustainably on earth. Expanding breadth of Pharma Innovation into neglected diseases results in global linkages that revitalizes global health diplomacy.Hotez 16, Peter J. Blue marble health: an innovative plan to fight diseases of the poor amid wealth. JHU Press, 2016. (Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology)Elmer AND including Mali, Cote d’Ivoire, Mozambique, Cameroon, Burkina Faso, and Niger, as well as Nigeria. Solves hotspot escalationNang and Martin 17, Roberto N., and Keith Martin. "Global health diplomacy: A new strategic defense pillar." Military medicine 182.1-2 (2017): 1456-1460. (MC, Global Health Division, Uniformed Services University of the Health Sciences)Elmer AND United States has the ability and authority to do so in the national and international interest. 1AC: PlanPlan – The member nations of the World Trade Organization ought to reduce intellectual property protections for medicines by implementing a one-and-done approach for patent protection.The Plan solves Evergreening.Feldman 3 Robin Feldman 2-11-2019 "‘One-and-done’ for new drugs could cut patent thickets and boost generic competition" https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/ (Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson ’54 Distinguished Professor of Law Chair, and Director of the Center for Innovation)SidK + Elmer AND right now, the incentives for creating patent walls are just too great. Reforming the Patent Process would lower Drug Prices and incentivize Pharma Innovation by revitalizing the Market.Stanbrook 13, Matthew B. "Limiting "evergreening" for a better balance of drug innovation incentives." (2013): 939-939. (MD (University of Toronto) PhD (University of Toronto))Elmer AND but to invest more in innovative drug development to maintain their profits. | 9/18/21 |
SO - LARP - Evergreening v2Tournament: Yale University Invitational 2021 | Round: 3 | Opponent: Scarsdale OL | Judge: David Herrera AND look for new things, not to recycle existing drugs for minimal benefit. The only major study confirms our Internal Link – Evergreening decimates competition by resulting in functional monopolies AND billions of dollars while increasing the incentives for pharmaceutical companies to achieve breakthroughs." Only innovation now solves AMR super-bugs — timeframe’s key. AND generations to come and secure the future from drug-resistant diseases." Extinction - generic defense doesn’t apply. AND A flu-like disease could kill more than 33 million people in 250 days.3 Expanding breadth of Pharma Innovation into neglected diseases results in global linkages that revitalizes global health diplomacy. AND including Mali, Cote d’Ivoire, Mozambique, Cameroon, Burkina Faso, and Niger, as well as Nigeria. Solves hotspot escalation AND United States has the ability and authority to do so in the national and international interest. 1AC: Plan AND right now, the incentives for creating patent walls are just too great. Reforming the Patent Process would lower Drug Prices and incentivize Pharma Innovation by revitalizing the Market. AND but to invest more in innovative drug development to maintain their profits. | 9/18/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
9/18/21 | christopherbao2@gmailcom |
|